212 related articles for article (PubMed ID: 21251329)
1. p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.
Bourdon JC; Khoury MP; Diot A; Baker L; Fernandes K; Aoubala M; Quinlan P; Purdie CA; Jordan LB; Prats AC; Lane DP; Thompson AM
Breast Cancer Res; 2011 Jan; 13(1):R7. PubMed ID: 21251329
[TBL] [Abstract][Full Text] [Related]
2. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.
Avery-Kiejda KA; Morten B; Wong-Brown MW; Mathe A; Scott RJ
Carcinogenesis; 2014 Mar; 35(3):586-96. PubMed ID: 24336193
[TBL] [Abstract][Full Text] [Related]
3. Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
Silden E; Hjelle SM; Wergeland L; Sulen A; Andresen V; Bourdon JC; Micklem DR; McCormack E; Gjertsen BT
PLoS One; 2013; 8(2):e56276. PubMed ID: 23409163
[TBL] [Abstract][Full Text] [Related]
4. Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.
Marcel V; Fernandes K; Terrier O; Lane DP; Bourdon JC
Cell Death Differ; 2014 Sep; 21(9):1377-87. PubMed ID: 24926616
[TBL] [Abstract][Full Text] [Related]
5. p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-up.
Zhang H; Zhao Y; Sun P; Zhao M; Su Z; Jin X; Song W
Carcinogenesis; 2018 Mar; 39(3):368-374. PubMed ID: 29346503
[TBL] [Abstract][Full Text] [Related]
6. High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.
Bischof K; Knappskog S; Stefansson I; McCormack EM; Trovik J; Werner HMJ; Woie K; Gjertsen BT; Bjorge L
BMC Cancer; 2018 Jun; 18(1):684. PubMed ID: 29940909
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
[No Abstract] [Full Text] [Related]
8. Expression of p53 isoforms in renal cell carcinoma.
Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
[TBL] [Abstract][Full Text] [Related]
9. Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.
Bischof K; Knappskog S; Hjelle SM; Stefansson I; Woie K; Salvesen HB; Gjertsen BT; Bjorge L
Sci Rep; 2019 Mar; 9(1):5244. PubMed ID: 30918304
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
Gudikote JP; Cascone T; Poteete A; Sitthideatphaiboon P; Wu Q; Morikawa N; Zhang F; Peng S; Tong P; Li L; Shen L; Nilsson M; Jones P; Sulman EP; Wang J; Bourdon JC; Johnson FM; Heymach JV
J Biol Chem; 2021 Nov; 297(5):101163. PubMed ID: 34481841
[TBL] [Abstract][Full Text] [Related]
11. Role of p53β in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53.
Ji W; Ma J; Zhang H; Zhong H; Li L; Ding N; Jiao J; Gao Z
Mol Med Rep; 2015 Jul; 12(1):691-5. PubMed ID: 25695150
[TBL] [Abstract][Full Text] [Related]
12. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
13. p53 Protein Isoform Profiles in AML: Correlation with Distinct Differentiation Stages and Response to Epigenetic Differentiation Therapy.
Haaland I; Hjelle SM; Reikvam H; Sulen A; Ryningen A; McCormack E; Bruserud Ø; Gjertsen BT
Cells; 2021 Apr; 10(4):. PubMed ID: 33917201
[TBL] [Abstract][Full Text] [Related]
14. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53.
Graupner V; Schulze-Osthoff K; Essmann F; Jänicke RU
Cell Cycle; 2009 Apr; 8(8):1238-48. PubMed ID: 19305147
[TBL] [Abstract][Full Text] [Related]
16. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.
Sjögren S; Inganäs M; Norberg T; Lindgren A; Nordgren H; Holmberg L; Bergh J
J Natl Cancer Inst; 1996 Feb; 88(3-4):173-82. PubMed ID: 8632491
[TBL] [Abstract][Full Text] [Related]
17. p53 mutation, deprivation and poor prognosis in primary breast cancer.
Baker L; Quinlan PR; Patten N; Ashfield A; Birse-Stewart-Bell LJ; McCowan C; Bourdon JC; Purdie CA; Jordan LB; Dewar JA; Wu L; Thompson AM
Br J Cancer; 2010 Feb; 102(4):719-26. PubMed ID: 20104224
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
20. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
